E-ISSN 2534-9821
 

Original Research 


Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study

Janardhana Rao Srerama, Spandana Valapula, Kameswara Rao A.

Abstract
The current COVID-19 pandemic has created yet another healthcare issue, with the emergence of a fungal disease that has resulted in a higher fatality rate. COVID-19 patients are predisposed to fungal infections such as mucormycosis, which has been reported in patients who are currently battling and those who have recently recovered, particularly those who are medically compromised. There has been a recent increase in the incidence of rhino--maxillary mucormycosis, which has become an emerging problem. We report cases of rhino-maxillary mucormycosis presenting with early oral manifestations to help in early diagnosis and treatment.
Methods: We retrospectively investigated fourteen cases of rhino-maxillary mucormycosis presenting initially with oral findings in post-COVID-19 diabetic patients who reported to the Department of Dental surgery, Andhra Medical College, Visakhapatnam, India.
Statistical analysis: The data were analyzed for age distribution, gender variation, presence of particular clinical signs and symptoms, and correlation of clinical and histopathological and radiological findings. Using statistical software SPSS V2, the Student t-test and chi-square test were applied to the data. P-value equal to or less than 0.05 is considered statistically significant (P<0.05).
Results: There was a statistically (P<0.05) significant gender variation, males showed marked predominance(79%), prominent age distribution observed in middle age (40-60 y) when compared to younger and older age group, and a significant correlation between clinical, histopathological and radiological findings were observed.
Conclusions: Rhino-maxillary mucormycosis is a fatal, emerging fungal infection in COIVD- 19 diabetic patients requiring multidisciplinary surgical and medical management. It is observed that early oral manifestations are present in these patients; early detection of these cases through a thorough examination and proper interpretation of clinical and other investigatory findings may prevent the further worsening of infection, helps to save the patient’s life and to make the better prognosis of this deadly disease.

Key words: Mucormycosis, COVID 19, fungal infection, immunocompromised patients


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Janardhana Rao Srerama
Articles by Spandana Valapula
Articles by Kameswara Rao A
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Srerama JR, Valapula S, A KR. Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study. Int J Med Rev Case Rep. 2022; 6(11): 78-83. doi:10.5455/IJMRCR.172-1647704858


Web Style

Srerama JR, Valapula S, A KR. Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study. https://www.mdpub.net/?mno=103712 [Access: December 05, 2023]. doi:10.5455/IJMRCR.172-1647704858


AMA (American Medical Association) Style

Srerama JR, Valapula S, A KR. Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study. Int J Med Rev Case Rep. 2022; 6(11): 78-83. doi:10.5455/IJMRCR.172-1647704858



Vancouver/ICMJE Style

Srerama JR, Valapula S, A KR. Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study. Int J Med Rev Case Rep. (2022), [cited December 05, 2023]; 6(11): 78-83. doi:10.5455/IJMRCR.172-1647704858



Harvard Style

Srerama, J. R., Valapula, . S. & A, . K. R. (2022) Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study. Int J Med Rev Case Rep, 6 (11), 78-83. doi:10.5455/IJMRCR.172-1647704858



Turabian Style

Srerama, Janardhana Rao, Spandana Valapula, and Kameswara Rao A. 2022. Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study. International Journal of Medical Reviews and Case Reports, 6 (11), 78-83. doi:10.5455/IJMRCR.172-1647704858



Chicago Style

Srerama, Janardhana Rao, Spandana Valapula, and Kameswara Rao A. "Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study." International Journal of Medical Reviews and Case Reports 6 (2022), 78-83. doi:10.5455/IJMRCR.172-1647704858



MLA (The Modern Language Association) Style

Srerama, Janardhana Rao, Spandana Valapula, and Kameswara Rao A. "Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study." International Journal of Medical Reviews and Case Reports 6.11 (2022), 78-83. Print. doi:10.5455/IJMRCR.172-1647704858



APA (American Psychological Association) Style

Srerama, J. R., Valapula, . S. & A, . K. R. (2022) Rhino-maxillary mucormycosis in COVID 19-diabetic patients with early oral manifestations: A retrospective study. International Journal of Medical Reviews and Case Reports, 6 (11), 78-83. doi:10.5455/IJMRCR.172-1647704858